Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON35169
NL-OMON35169
Not yet recruiting
Not Applicable

Bone augmentation with autologous adipose tissue-derived mesenchymal stem cells and calcium phosphate carriers in the human maxillary sinus floor elevation model - Adipose stem cells in the sinus floor elevation model (STEM CELL LIFT)

Vrije Universiteit Medisch Centrum0 sites20 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsjaw bone athrophyjaw bone loss10005959

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
jaw bone athrophy
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
20
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- minimal bone height of 4 mm at planned implant site(s)
  • •\- no local need for horizontal bone augmentation
  • •\- healthy appearance sinus maxillaris
  • •\- smoking below 10 sigarettes a day
  • •\- Age 18 years or older

Exclusion Criteria

  • •\- History of malignancy or chronic infectious disease (i.e. HIV, Hepatitis)
  • •\- irradiation history in jaw area
  • •\- destructive sinus surgery indicated during anamnesis
  • •\- endocarditis or heart valve abnormalities, or heart valve prostheses
  • •\- abnormalities in the immune system, or use of immune suppressants
  • •\- severe bone metabolic disorders (e.g. severe osteoporosis treated with bisphosphonates)
  • •\- Chronic use (\>7 consecutive days) of anticoagulants (such as aspirin) or Non\-Steroidal Anti\-Inflammatory Drugs (NSAIDs) within 15 days prior to lipoaspriation
  • •\- Signs or symptoms of infection at the time of the surgical procedure
  • •\- pregnant or nursing, or intention to become pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Onderzoek naar kaakbotophoging met kunstbot en stamcellen voor tandwortelimplantate
NL-OMON24484VU University medical center, De Boelelaan 1117, 1081 HV Amsterdam15
Completed
Not Applicable
Bone augmentation with tissue engineered boneAtrophy of alveolar bone
JPRN-UMIN000006720Department of Oral and Maxillofacial Surgery, Nagoya University Hospital100
Completed
Not Applicable
Development of Bone Grafts Using Adipose Derived Stem Cells and Different ScaffoldsOverweight
NCT01218945University of Zurich33
Active, not recruiting
Phase 1
Adipose Cell Derived Regenerative Endothelial and Angiogenic MedicinePatients with rest pain or ischemic ulcers/gangrene of the lower limb and without option for revascularization or poor option. Or patients with with rest pain or ischemic ulcers and persistent CLI after revascularization, or with severe cardiac, respiratory or renal disease who are at increased risk of complication from surgery or anesthesia, or with moderately severe or severe heart failure, severe or very severe Chronic Obstructive Pulmonary disease or severe renal disease.Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2018-000967-10-FRniversity Hospital Toulouse43
Completed
Not Applicable
Effect of Autologous Adipose Tissue Derived Mesenchymal Stem Cells injection in Rotator Cuff DiseaseDiseases of the musculo-skeletal system and connective tissue
KCT0001523Seoul Metropolitan Government Seoul National University Boramae Medical Center18